Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for February 2011
February 1, 2011
- Medicago Reports Positive Phase II Interim Results for its Avian Flu Pandemic Vaccine
- Oncolytic Virus Portfolio Preclinical Research Publication
- Bellus Health Announces Phase I Results of Prodrug NRM8499 Intended for the Treatment of Alzheimer's disease
- Cells' Energy Factories Linked to Damaging Inflammation
- Study Examines Incident Hepatitis C Infection in HIV-Infected Men
February 2, 2011
- Positive Top-Line Phase III Data in Type 2 Diabetes Achieved for lixisenatide Once-Daily vs. Exenatide Twice-Daily
- Cortex's AMPAKINE CX1739 Improves Respiratory Parameters in Obstructive Sleep Apnea Patients
- PROLOR Biotech Announces Positive Preclinical Results From Long-Acting Factor IX Comparative Study
- BioSante Pharmaceuticals, Inc. To Provide Update on LibiGel Safety Study at International Society for the Study of Women's Sexual Health Meeting
- The New England Journal of Medicine Publishes Results of Fidaxomicin Phase 3 Trial Showing Significantly Lower Recurrence Rates and Improved Global Cure Rates Compared to Vancomycin in Patients with Clostridium difficile Infection (CDI)
- Allon announces davunetide improves motor function and brain pathology in a Parkinson?s disease model
- New Study Alters Long Held Beliefs about Shingles
- Meta-analysis of interferon alfa studies cited as "Notable Advance" in Best of 2010 Report By American Society of Clinical oncology
- Metamark Genetics Announces Landmark Prostate Cancer Study Published in Nature
- Derma Sciences to Hold Conference Call to Discuss Results from Phase 2 DSC127 Trial in Diabetic Foot Ulcers February 3
February 3, 2011
- Safety Monitoring Committee Meeting For Nymox Pivotal Phase 3 NX-1207 Trials Indicates Favorable Safety Profile
- Expert Panel Publishes Findings on Benefits of Underutilized Intrathecal Baclofen Therapy for Severe Spasticity in Multiple Sclerosis Patients
- Promising new treatment for Parkinson's improves motor control
- Progen's PG545 Positive Anti-Cancer Data Published in British Journal of Cancer
- New Analysis Published in Multiple Sclerosis Journal Recommends Intrathecal Baclofen (Itb) Therapy for Ms Patients Suffering From Spasticity
- Welichem Successfully Completes Two Phase Ii Clinical Trials of Wbi-1001 Cream in Patients With Psoriasis and Atopic Dermatitis
- Zealand Pharma: Positive top-line phase III data in type 2 diabetes achieved for lixisenatide once-daily vs. exenatide twice-daily
- Maternal Stroke History Tied to Women's Heart Attack Risk
February 4, 2011
- EntreMed's ENMD-2076 Phase 1 Results Demonstrating Activity in Refractory Cancer Patients Accepted For Publication in Clinical Cancer Research
- KYTHERA Biopharmaceuticals Announces Positive Results from Phase IIb Study with ATX-101 Demonstrating Reduction of Submental Fat
- Photocure Announces Positive Allumera? Trial Results For Delivering Significant Skin Appearance Improvements
- Photocure Announces Positive Allumera Trial Results for Delivering Significant Skin Appearance Improvements
- Journal of Clinical Oncology Publishes Clinical Trial Results of VELCADE Combination in Aggressive Subtypes of Non-Hodgkin Lymphoma
- Enbrel (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis
- Dermatologists Caution That Atopic Dermatitis Is a Strong Precursor to Food Allergies
- New England Journal of Medicine Publishes Efficacy and Safety Data for GARDASIL in Males
- Inspiration Biopharmaceuticals Demonstrates Non-Inferiority of IB1001, Its Recombinant Factor IX for Hemophilia B
- Ipsen's Partner Inspiration Biopharmaceuticals Announces Non-Inferiority of IB1001, Its Recombinant Factor IX for Hemophilia B
- Derma Sciences Reports Positive Top-Line Results from DSC127 Phase 2 Trial in Patients with Diabetic Foot Ulcers
- pSivida Announces Positive Results from the 36 Month Readout of Completed Phase 3 FAME Study of Iluvien in Patients with Diabetic Macular Edema
February 7, 2011
- Human Genome Sciences and GlaxoSmithKline Announce Publication of BLISS-52 Phase 3 Study Results for Benlysta in The Lancet
- Early Successful Readout of Tarceva Study in a Distinct Form of Lung Cancer
- Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans
- Depomed's Reports Results of Phase 1 Trial of Twice-daily Formulation of DM-1992 in Parkinson's Patients
- Native American Ancestry Linked to Greater Risk of Relapse in Young Leukemia Patients
- EpiCept Reports Positive Results from EpiCept NP-1 Trial in Patients with Chemotherapy-Induced Peripheral Neuropathy
February 8, 2011
- Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
- Hope for stroke victims
- Ausio Pharmaceutical?s ER?Agonist AUS-131 is WellTolerated in First Human Clinical Trials
February 9, 2011
- Teva Announces Results from a Phase III Study for Qnaze Nasal Aerosol in Perennial Allergic Rhinitis
- Safter Treatment for Menopause? AUS-131 Well Tolerated in 1st Human Clinical Trials
- QLT Announces Phase II Clinical Trial Results for the Olopatadine Punctal Plug Delivery System (O-PPDS)
- NOVAVAX to Present H1N1 VLP Influenza Vaccine Clinical Data at 7th World Health Organization (WHO) Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials
- Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET
- BioAlliance Pharma Presents the Results of an International Survey Performed with Nielsen in Patients Suffering from Herpes Labialis
- Protein May Be Key to New Treatment in a Childhood Cancer
- Adeona's Alzheimer's Disease Pivotal Clinical Study Results Abstract Accepted for Presentation at the American Academy of Neurology's 63rd Annual Meeting
February 10, 2011
- Novartis Drug Afinitor Extends Progression-Free Survival in Patients With Advanced Pancreatic NET, Study Published in NEJM Shows
- Novartis Studies Show Onbrez Breezhaler Plus Tiotropium Provided Greater Increase in Lung Function Than Tiotropium Alone
- Promedior Announces Publication of New Research Demonstrating Pentraxin-2/SAP is a Potent Inhibitor of Pulmonary Fibrosis
- Regulus Therapeutics to Present Multiple Platform and Pipeline Advancements at the Keystone Symposium on microRNAs
- PharmAthene Presents New Anthrax Anti-Toxin Data at the ASM Biodefense and Emerging Diseases Research Meeting
- CytRx's Bafetinib Demonstrates Ability to Prevent Cancer-Related Bone Loss
- Tolerx Presents Preclinical Data on Novel Cancer Immunotherapeutic, TRX518, a First-in-Class Anti-GITR Antibody
- DURECT Reports Data From European Phase IIb Shoulder Study of Posidur) (SABER-Bupivacaine) and Amendment of the Nycomed Agreement
- New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin in Reducing Stroke and Systemic Embolism in Patients with Atrial Fibrillation Unsuitable for Warfarin Therapy
February 11, 2011
- Positive TB-402(Anti-Factor VIII Antibody) Phase II Data Published in Journal of Thrombosis and Haemostasis
- Renovo Announces the Result of Its First EU Phase III Trial of Juvista in Scar Revision Surgery
- Lucentis Phase III Study Meets Primary Endpoint for Improving Vision in Patients With Diabetic Macular Edema (DME)
- American Stroke Association Meeting Report: Acute Anemia Linked to Silent Strokes in Children
- CAVATAK and Pancreatic Cancer Preclinical Research Presentation
February 14, 2011
- Oncolytics Biotech Inc. Meets Primary Endpoint for First Part of U.S. Phase 2 Pancreatic Cancer Clinical Trial
- AVEO Pharmaceuticals' Tivozanib Clinical Data Featured at the 2011 ASCO Genitourinary Cancers Symposium
- BioSante Pharmaceuticals Reports Positive LibiGel Safety Data in Phase III Program
- Blood Pressure-Lowering Medication Not Beneficial in Acute Stroke
- Idera Pharmaceuticals Presents Data on IMO-3100 in Preclinical Lupus Model Showing Suppression of Disease Progression Parameters
- Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease
- Napo Pharmaceuticals Announces Successful Treatment of Acute Adult Watery Diarrhea
- Treating Diabetes With Less Need for Insulin
- BioSante Pharmaceuticals Reports Positive LibiGel Safety Data in Phase III Program
- Specialists On Call And UCLA Present New Stroke Data
- Oncolytics Biotech Inc. Meets Primary Endpoint for First Part of U.S. Phase 2 Pancreatic Cancer Clinical Trial
February 15, 2011
- BioSante Presents Data Showing Female Sexual Dysfunction is a Significant Unmet Medical Need
- Liver Cancer Rapidly Increasing in California Hispanic Men
February 16, 2011
- Study Confirms Third Trimester Amniotic Fluid a Reliable Source of Stem Cells for Regenerative Medicine and Stem Cell Banking
- Treatment for manic-depressive illness restores brain volume deficits
- Water softeners not found to improve childhood eczema
- Tau-induced memory loss in Alzheimer?s mice is reversible
- Amicus Therapeutics Provides Positive Data Update from Phase 2 Long-Term Extension Study of Amigal for Fabry Disease
- International Stem Cell Demonstrates Progress in the Use of Immune Matched Human Parthenogenetic Stem Cells to Promote the Development of Therapies for Diabetes and Liver Diseases
- Ceregene Reports New Findings Regarding How Parkinson's Brains Respond to Neurotrophic Factors
- Medicago invited to present at the 7th WHO's meeting on evaluation of pandemic influenza prototype vaccines in clinical trials
- Progen's PG545 Positive Anti-Cancer Data Published in British Journal of Cancer
- Medivation & Astellas Announce Positive New Data for MDV3100
- Alkermes Announces Positive Preliminary Results from Phase 2 Study of ALKS 37 for Treatment of Opioid-Induced Bowel Dysfunction
- New Pneumococcal Vaccine Approach Successful in Early Tests
February 17, 2011
February 18, 2011
- NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting
- Cabozantinib (XL184) Phase 2 Data Demonstrate Encouraging Clinical Activity in Patients with Castration-Resistant Prostate Cancer
- Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine
- Urocidin Phase III Clinical Trial Results to be Presented at EAU and AUA Conferences
- Drug Therapy Shows Significant Benefit in Treating A Leading Cause of Childhood Blindness
- Phase III Data Published in The Lancet Show Baxter's PREFLUCEL Protective Against Seasonal Influenza
- Caldolor Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
- Fibrocell Science, Inc. Announces Positive Results of Its Pilot Study for Treatment of Vocal Fold Scarring With Fibroblasts
- Dendreon Announces Presentation of Provenge Data at the 2011 Genitourinary Cancers Symposium Annual Meeting
- Active Biotech's TASQ prostate cancer project presented at 2011 Genitourinary Cancers Symposium
February 19, 2011
- Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across All Endpoints
- Progenics Reports Positive Preliminary Data from Ongoing Phase 1 Clinical Study of PSMA ADC
February 22, 2011
- Update on progress of Phase I/IIa Clinical Trial
- Verona Pharma announces positive results for RPL554 in mild asthma at higher doses
- Dynavax Reports New Phase 1a and Phase 1b Data for Universal Flu Vaccine Candidate
- High Cholesterol and Blood Pressure in Middle Age Tied to Early Memory Problems
- Using Amphetamines May Increase Risk of Parkinson's Disease
- Arthritis Strikes 3 Million U.S. Hispanics
- NexBio's DAS181 (Fludase) Improved Symptoms in a Severely Immunocompromised Patient with Parainfluenza Pneumonitis
- Protalix to Present New Data on taliglucerase alfa and Preclinical Data on Oral Enzyme glucocerebrosidase at the WORLD Lysosomal Disease Network Symposium
- Dynavax Reports Additional Positive Phase 1B Immunogenicity Data for Hepatitis B Therapy Candidate
February 23, 2011
- Phase 3 Study of VX-770 Showed Profound and Sustained Improvements in Lung Function (FEV1) and Other Measures of Disease Among People With a Specific Type of Cystic Fibrosis
- ProtoKinetix Targets Diabetes and Other Diseases Caused by Inflammation
- BrainStorm's NurOwn Stem Cell Technology Shows Promise for Treating Sciatic Nerve Injury
- Advancell Announces Positive Phase I/IIa Results With Acadra (Acadesine) in Chronic Lymphocytic Leukemia - CLL
- New Long-Acting Local Anesthetic Derived From Algae Effectively Blocks Pain in Surgical Patients
February 24, 2011
- PolyMedix Successfully Completes Phase 1 Exposure Escalation Safety Study With PMX-30063 Antibiotic
- Disseminated Adenovirus Infection Eradicated in a Pediatric Hematopoietic Stem Cell Transplantation Recipient Who Received Chimerix's Lead Antiviral CMX001
- The Journal of Clinical Oncology Publishes Phase 3 XGEVA (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
- Fate Therapeutics Announces Emerging Data From Proof-of-Concept FT1050 Clinical Trial and Receives Orphan Drug Designation
- Helix BioMedix Peptides Featured in American Academy of Dermatology Annual Meeting Research Posters Addressing Cellulite, Rosacea
- Pieris to Present Interim Data From the Phase I Clinical Trial of PRS-050 at Molecular Medicine Tri-Conference
- Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus
- KYTHERA Biopharmaceuticals Presents Positive Data from Phase IIb Study with ATX-101 Demonstrating Reduction of Submental Fat
- Cannabis Science Extracts Kill Cancer Cells In Cancer Patients Being Treated Through Its Licensed Distributor Rockbrook
- High Rates of Pathological Complete Response in Patients with Advanced Esophageal Cancer in OPAXIO Phase II Study Reported in American Journal of Clinical Oncology
February 25, 2011
- Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation
- Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study
- Phase 2 Lymphoseek® (Tilmanocept) Data Published Online in Annals of Surgical Oncology
- Neovacs Presents Successful Results of Crohn's Disease Drug Trial at European Crohn's & Colitis Congress
February 28, 2011
- S*BIO's Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models
- ARCALYST (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy
- Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
- Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
- Synta Announces Encouraging Preliminary Results for Ganetespib (STA-9090) in Phase 2 Non-small Cell Lung Cancer Trial
- 4SC Presents Final Phase IIa Data on Vidofludimus in Inflammatory Bowel Disease Study at the 6th ECCO IBD Conference
- Genetically Modified Fungi Kill Malaria-causing Parasites in Mosquitoes
- Peregrine Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting
